** Shares of Natco Pharma NATP.NS down 0.7% at 903 rupees, while Nifty Pharma index up 1.2%
** Earlier was at 871 rupees, its lowest level since June 27
** Co reported 28.1% y/y fall in Q1 consol net profit as expenses rose
** Co says business faced pricing pressure in U.S. product portfolio, incurred increased R&D expenses on account of high value projects
** Average rating by 8 analysts is "hold"; median PT is 1,040.5 rupees - data compiled by LSEG
** YTD, NATP down 35.1% vs 6.7% fall in Nifty Pharma index
($1 = 87.6138 Indian rupees)
(Reporting by Meenakshi Maidas in Bengaluru)
((meenakshi.maidas@thomsonreuters.com;))